These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3238031)

  • 21. [Aspects of protein metabolism in chronic uremia. Study completed with the help of nitrogen balance during a course of periodic hemodialysis].
    Fiaschi E; Campanacci L; Maschio G; D'Angelo A; Bonadonna A; Ossi E
    Minerva Nefrol; 1972; 19(2):70-82. PubMed ID: 4681263
    [No Abstract]   [Full Text] [Related]  

  • 22. LIGHT--a new member of the TNF superfamily in the plasma, dialysate and urine of uremic patients; the impact of residual diuresis and presence of viral hepatitis.
    Pawlak K; Pawlak D; Mysliwiec M
    Clin Biochem; 2007 Nov; 40(16-17):1240-4. PubMed ID: 17826757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of peritoneal dialysis on intracellular free amino acids in muscle from uraemic patients.
    Bergström J; Fürst P; Norée LO; Vinnars E
    Proc Eur Dial Transplant Assoc; 1972; 9():393-401. PubMed ID: 4668917
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the behavior of phenols and creatinine in renal insufficiency, especilly in chronic dialysis patients].
    Jutzler GA; Kramer HJ; Keller HE; Kramer H; Doenecke F
    Arch Klin Med; 1968; 214(3):214-43. PubMed ID: 5683859
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of phosphate retention and hyperphosphatemia in uremia.
    Hercz G; Coburn JW
    Kidney Int Suppl; 1987 Oct; 22():S215-20. PubMed ID: 3323615
    [No Abstract]   [Full Text] [Related]  

  • 26. Low Ca2+ dialysate. Effects on bone metabolism in the course of paired filtration dialysis.
    Carozzi S; Nasini MG; Pietrucci A; Costa M; Mantero R
    ASAIO J; 1994; 40(3):M683-5. PubMed ID: 8555601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The abnormalities of carbohydrate and lipid metabolism in uremia. A study in 20 hemodialyzed patients (author's transl)].
    Prinseau J; Meyrier A; Domart M; Brault D; Ragot J; Etienne J
    Pathol Biol (Paris); 1980 Feb; 28(2):101-6. PubMed ID: 7005829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tetracycline resistance in Mycoplasma hominis.
    Christiansson A; Mårdh PA
    Sex Transm Dis; 1983; 10(4 Suppl):371-3. PubMed ID: 6665682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Designing facial amphiphiles for the stabilization of integral membrane proteins.
    Zhang Q; Ma X; Ward A; Hong WX; Jaakola VP; Stevens RC; Finn MG; Chang G
    Angew Chem Int Ed Engl; 2007; 46(37):7023-5. PubMed ID: 17691085
    [No Abstract]   [Full Text] [Related]  

  • 30. [GH, insulin and glucide intolerance in chronic uremia. Changes during hemodialysis treatment and after renal transplantation].
    Orsoni G; Capelli M; Scolari MP; Vangelista A; Bonomini V
    Minerva Nefrol; 1980; 27(4):655-8. PubMed ID: 7019773
    [No Abstract]   [Full Text] [Related]  

  • 31. [Biochemical and functional characteristics of erythrocyte membranes in sportsmens with anemia].
    Hunina LM; Oliĭnyk SA; Ivanov SV
    Fiziol Zh (1994); 2007; 53(3):43-50. PubMed ID: 17725043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid monolayers: why use half a membrane to characterize protein-membrane interactions?
    Brockman H
    Curr Opin Struct Biol; 1999 Aug; 9(4):438-43. PubMed ID: 10449364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscle in chronic uremia--a histochemical and morphometric study of human quadriceps muscle biopsies.
    Shah AJ; Sahgal V; Quintanilla AP; Subramani V; Singh H; Hughes R
    Clin Neuropathol; 1983; 2(2):83-9. PubMed ID: 6851301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Red blood cell membrane lipid peroxidation and chronic haemolysis in haemodialysis patients.
    Taccone-Gallucci M; Lubrano R; Mazzarella V; Bandino D; Meloni C; Morosetti M; Elli M; Giardini O; Boffo V; Tozzo C
    Life Support Syst; 1985; 3 Suppl 1():41-4. PubMed ID: 3870599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Periodic hemodialysis in non-selected patients with chronic terminal uremia. Results of a study made in a Northeastern Lombardia District Hospital with special regard to survival and influence of age (1573 cases of extracorporeal dialysis in 22 patients)].
    Gargano N
    Minerva Med; 1973 Sep; 64(63):3283-91. PubMed ID: 4774224
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in plasma-membrane lipid composition: a strategy for acclimation to copper stress.
    Berglund AH; Quartacci MF; Liljenberg C
    Biochem Soc Trans; 2000 Dec; 28(6):905-7. PubMed ID: 11171252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Exchangeable sodium and water spaces in chronic uremia during intermittent hemodialytic treatment].
    Romagnoli GF; Mendola R; Bruschi E; Borsatti A; Muolo A; Mioni G; Huber W
    Minerva Nefrol; 1968; 15(5):336-41. PubMed ID: 5743462
    [No Abstract]   [Full Text] [Related]  

  • 38. [The nature of renal lesions and periodic hemodialysis].
    Bonomini V; Mioli V; Albertazzi A; Vangelista A
    Minerva Nefrol; 1972; 19(2):50-9. PubMed ID: 4681261
    [No Abstract]   [Full Text] [Related]  

  • 39. [The importance of amino acid substitution for the protein metabolism in patients treated by periodical hemodialysis].
    Kult J; von Finck M; Frank P; Heidland A
    Infusionstherapie (1973); 1973 Dec; 1(2):124-7. PubMed ID: 4219012
    [No Abstract]   [Full Text] [Related]  

  • 40. [How is our need for active treatment of uremia provided for?].
    Bergström J; Erlanson P
    Lakartidningen; 1976 Dec; 73(50):4434-6. PubMed ID: 994592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.